Anti-Human FLT1 Antibody with collaborator-tested evidence for IF/ICC.
Know who made it. See the evidence. Buy through one marketplace.
Anti-Human FLT1 Antibody is a research-use antibody from Elabscience for studying FLT1 in IF/ICC workflows with listed reactivity for Human. Specifications and supporting documents below should be reviewed when planning the experiment.
Fully tested in-house by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Species | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP |
|---|---|---|---|---|---|---|---|
| Human |
This product is manufactured by Elabscience and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
Fms related receptor tyrosine kinase 1 (FLT1), also known as vascular endothelial growth factor receptor 1 (VEGFR1), is a VEGF-family receptor. This ABMIUM record links human FLT1 (NCBI Gene 2321; UniProt P17948) to catalogue-backed products.
Biological function: FLT1/VEGFR1 is a receptor tyrosine kinase that binds vascular endothelial growth factor ligands and placental growth factor. It contributes to angiogenesis and vasculogenesis, with membrane-bound and soluble receptor isoforms.
